A clinical trail on parangisakkai chooranam in the management of soothagavaayu(PCOD)

A prospective open labelled, single arm, non-randomized, single centric, phase II clinical trial to evaluate the efficacy of Parangisakkai chooranam in the management of soothagavaayu(PCOD)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069031

Enrollment

Registered

2024-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: PARANGISAKKAI CHOORANAM: 3-6 grams twice a day orally with hot water for 3 months Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.Menstrual irregularities (Secondary amenorrhea) (Oligo amenorrhea) 2.Hyperandrogenism(clinical/Biochemical) 3.polycystic ovaries (unilateral/bilateral) 4.seeking treatment for PCOS induced infertility

Exclusion criteria

Exclusion criteria: 1.Diabetes mellitus 2.Hypertension 3.pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
It is mainly assessed for minimum 3 menstrual cycles by 1.Regulation of menstrual cycle 2.Regulation of hormonal profile 3.Disappearance/reduction in the size or number of cyst. Regulation of hormonal profileTimepoint: 40 days	—

Secondary

Measure	Time frame
To evaluate physicochemical, phytochemicals, biochemical analysis of clinical trial drug To evaluate the safety profile for acute and subacute toxicity of the trial drug To evaluate Antioxidant, Antidiabetic activity of the trial drug To evaluate the pharmacological analysis of the clinical trial drug To evaluate various siddha parameters.Timepoint: 6 months	—

Countries

India

Contacts

Public ContactProf Dr T Komalavalli

Government Siddha Medical College and hospital, Palayamkottai

komalaarumugam1@gmail.com8248497477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026